Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
Region: All Regions > Asia > Japan
Category: All Categories > Life Sciences > Pharmaceuticals > Research & Development
(11 reports matching your criteria)
 
PharmaPoint: Chronic Myeloid Leukemia (CML) - Japan Drug Forecast and Market Analysis to 2022
4/30/2013 | published by: GlobalData
... to 2022”. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by the presence of the BCR-ABL fusion protein. The stage of CML is classified as chronic, accelerated or blast phase, ...  |  read more...
$4,995.00
Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Improve the Competitiveness of Japanese Players
4/29/2013 | published by: GBI Research
... latest research “Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Improve the Competitiveness of Japanese Players”. Japan’s pharmaceutical industry is the second largest in the world, ...  |  read more...
$3,500.00
PharmaPoint: Multiple Sclerosis - Japan Drug Forecast and Market Analysis to 2022
3/31/2013 | published by: GlobalData
... (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease management is dependent on life-long pharmacotherapy with disease-modifying ...  |  read more...
$4,995.00
Multiple Sclerosis - Japan Drug Forecast and Market Analysis to 2022
3/1/2013 | published by: GlobalData
... (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease management is dependent on life-long pharmacotherapy with disease-modifying ...  |  read more...
$4,995.00
PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022
2/15/2013 | published by: GlobalData
... characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. The AED market is currently dominated by UCB’s Keppra and GlaxoSmithKline’s Lamictal. ...  |  read more...
$4,995.00
2013 Japan Sexually-Transmitted Diseases: Market Outlook and Emerging Opportunities
12/21/2012 | published by: Venture Planning Group
... Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular ...  |  read more...
$2,400.00
Rheumatoid Arthritis Drugs Market in Japan 2011-2015
4/6/2012 | published by: Infiniti Research Limited
... rate of patients suffering from rheumatoid arthritis. The Rheumatoid Arthritis Drugs market in Japan has also been witnessing a trend of increasing number of collaborations among vendors. However, stringent regulatory requirements for approval of drugs ...  |  read more...
$1,500.00
Anti-cancer Drugs Market in Japan 2011-2015
4/5/2012 | published by: Infiniti Research Limited
... the number of cancer patients in the country. The Anti-cancer Drugs market in Japan has also been witnessing the trend of using a combination of cancer therapies for treatment. However, stringent government regulations in Japan ...  |  read more...
$1,500.00
Key Issues to Consider When Bringing Biologics to Market in Europe and Japan
7/28/2008 | published by: Decision Resources
... force in Europe and Japan, where they are well represented in companies' product pipelines. Issues that will make or break the successful integration of biologics in European and Japanese biopharmaceutical market include clinical trial design, ...  |  read more...
$1,125.00
Change Is Percolating Through Japan's Pharmaceutical Markets
9/12/2007 | published by: Decision Resources
... are strengthening their foothold in Japan by launching a wide variety of new drugs. To successfully navigate the changing waters of the world's second-largest pharmaceutical market, companies must understand today's evolving business environment and institute ...  |  read more...
$4,600.00
Pharmaceutical Product Lifecycle Management Forecast in APAC 2006-2012 (Databook)
7/9/2007 | published by: Datamonitor
... services PLM spending splits by Big Pharma and Biotech Global PLM spending splits by geographic region Highlights Datamonitor believes that the pharmaceutical industry, driven by an R&D productivity crisis and increasing pressures for regulatory compliance, ...  |  read more...
$1,295.00